Research programme: amylin receptor agonists - Kemia
Latest Information Update: 04 Nov 2017
At a glance
- Originator Kemia
- Class Small molecules
- Mechanism of Action Islet amyloid polypeptide stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Diabetes mellitus; Obesity
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for preclinical development in Diabetes-mellitus in USA (PO)
- 04 Nov 2017 No recent reports of development identified for preclinical development in Obesity in USA (PO)
- 26 Feb 2008 Preclinical development is ongoing